Francisco Javier
Burgos Revilla
Catedrático/a de Universidad
Netherlands Cancer Institute
Amsterda, HolandaPublikationen in Zusammenarbeit mit Forschern von Netherlands Cancer Institute (1)
2023
-
Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy
Minerva urology and nephrology, Vol. 75, Núm. 5, pp. 591-599